To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...

Kennedy vowed to “Make America Healthy Again,” has delivered an inconsistent message that has the nation’s top infectious ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Propranolol and metoprolol are beta-blockers taking to treat certain heart conditions. Learn more about their similarities ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Recent developments in the skincare industry have raised concerns over the safety of certain acne treatment products. The U.S. Food and Drug Administration (FDA) issued a recall alert on March 11, ...

A fire weather watch is in place across the area as a strong storm system approaches this weekend. K-State meteorologist Chip Redmond said the "bomb cyclone" will elevate the risk for fires developing ...